摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-Hydroxy-1-propan-2-yloxyethoxy)propan-1-ol

中文名称
——
中文别名
——
英文名称
2-(2-Hydroxy-1-propan-2-yloxyethoxy)propan-1-ol
英文别名
2-(2-hydroxy-1-propan-2-yloxyethoxy)propan-1-ol
2-(2-Hydroxy-1-propan-2-yloxyethoxy)propan-1-ol化学式
CAS
——
化学式
C8H18O4
mdl
——
分子量
178.23
InChiKey
RHZBXSSKLLCFCR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    12
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    58.9
  • 氢给体数:
    2
  • 氢受体数:
    4

文献信息

  • [EN] PROTEIN-POLYMER-DRUG CONJUGATES<br/>[FR] CONJUGUÉS MÉDICAMENT-POLYMÈRE-PROTÉINE
    申请人:ASANA BIOSCIENCES LLC
    公开号:WO2015054669A1
    公开(公告)日:2015-04-16
    A polymeric scaffold useful for conjugating with a protein based recognition-molecule (PBRM) to form a PBRM-polymer-drug conjugate is described herein. The scaffold includes one or more terminal maleimido groups. Also disclosed is a PBRM-polymer-drug conjugate prepared from the scaffold. Compositions comprising the conjugates, methods of their preparation, and methods of treating various disorders with the conjugates or their compositions are also described.
    本文描述了一种用于与基于蛋白质的识别分子(PBRM)共轭的聚合支架,以形成PBRM-聚合物-药物共轭物的聚合支架。该支架包括一个或多个末端马来酰亚胺基团。还公开了从该支架制备的PBRM-聚合物-药物共轭物。还描述了包括这些共轭物的组合物、它们的制备方法以及使用这些共轭物或它们的组合物治疗各种疾病的方法。
  • [EN] PROTEIN-POLYMER-DRUG CONJUGATES<br/>[FR] CONJUGUÉS PROTÉINE-POLYMÈRE-MÉDICAMENT
    申请人:MERSANA THERAPEUTICS INC
    公开号:WO2014093394A1
    公开(公告)日:2014-06-19
    A drug conjugate is provided herein. The conjugate comprises a protein based recognition-molecule (PBRM) and a polymeric carrier substituted with one or more -LD-D, the protein based recognition-molecule being connected to the polymeric carrier by Lp. Each occurrence of D is independently a therapeutic agent having a molecular weight < 5 kDa. LD and Lp are linkers connecting the therapeutic agent and PBRM to the polymeric carrier respectively. Also disclosed are polymeric scaffolds useful for conjugating with a PBRM to form a polymer- drug-PBRM conjugate described herein, compositions comprising the conjugates, methods of their preparation, and methods of treating various disorders with the conjugates or their compositions.
  • [EN] PROTEIN-POLYMER-DRUG CONJUGATES<br/>[FR] CONJUGUÉS DE MÉDICAMENT-PROTÉINE-POLYMÈRE
    申请人:MERSANA THERAPEUTICS INC
    公开号:WO2015054659A1
    公开(公告)日:2015-04-16
    A polymeric scaffold useful for conjugating with a protein based recognition-molecule (PBRM) to form a PBRM-polymer-drug conjugate is described herein. The scaffold includes one or more terminal maleimido groups. Also disclosed is a PBRM-polymer-drug conjugate prepared from the scaffold. Compositions comprising the conjugates, methods of their preparation, and methods of treating various disorders with the conjugates or their compositions are also described.
查看更多